Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 3/20 | 0.77 |
| ▸ | ADRA2A | P08913 | 3/20 | 0.77 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.77 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.77 |
| ▸ | TACR2 | P21452 | 2/20 | 0.77 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.77 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.77 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.77 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.77 |
| ▸ | LMNA | P02545 | 1/20 | 0.77 |
| ▸ | SHBG | P04278 | 1/20 | 0.77 |
| ▸ | TP53 | P04637 | 1/20 | 0.77 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.77 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.77 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.77 |
| ▸ | HTR2C | P28335 | 1/20 | 0.77 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.77 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.77 |
| ▸ | TST | Q16762 | 1/20 | 0.77 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.77 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9345284 | 1.00 | ESR1 (0.77) | ESR1ADRA2ASLC6A2ADORA3TACR2 | |
| SCHEMBL7784766 | 1.00 | ESR1 (0.77) | ESR1ADRA2ASLC6A2ADORA3TACR2 | |
| SCHEMBL9165397 | 1.00 | ESR1 (0.77) | ESR1ADRA2ASLC6A2ADORA3TACR2 | |
| SCHEMBL8398450 | 1.00 | ESR1 (0.77) | ESR1ADRA2ASLC6A2ADORA3TACR2 | |
| SCHEMBL4631265 | 1.00 | ESR1 (0.77) | ESR1ADRA2ASLC6A2ADORA3TACR2 | |
| SCHEMBL1447579 | 1.00 | ESR1 (0.77) | ESR1ADRA2ASLC6A2ADORA3TACR2 | |
| SCHEMBL9166790 | 1.00 | ESR1 (0.77) | ESR1ADRA2ASLC6A2ADORA3TACR2 | |
| SCHEMBL253453 | 1.00 | ESR1 (0.77) | ESR1ADRA2ASLC6A2ADORA3TACR2 | |
| SCHEMBL2777921 | 1.00 | ESR1 (0.77) | ESR1ADRA2ASLC6A2ADORA3TACR2 | |
| SCHEMBL449737 | 0.97 | ESR1 (0.77) | ESR1ADRA2ASLC6A2ADORA3TACR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 157 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111799052-B | Sintered neodymium iron boron magnet with surface function rete | 浙江中杭新材料科技有限公司 | 2022-11-15 | — | — | CN | claimed |
| CN-111799052-A | Sintered neodymium iron boron magnet with surface function rete | 浙江中杭新材料科技有限公司 | 2020-10-20 | — | — | CN | claimed |
| CN-106661219-B | Copolycarbonate resin composition and article comprising the same | 株式会社LG化学 | 2019-04-26 | — | — | CN | claimed |
| CN-109563336-A | Polycarbonate compositions and articles comprising the same | 株式会社LG化学 | 2019-04-02 | — | — | CN | claimed |
| CN-107108876-B | Copolycarbonate and composition containing same | 株式会社LG化学 | 2019-03-08 | — | — | CN | claimed |
| CN-105899607-B | Poly carbonate resin composition | LG化学株式会社 | 2018-11-16 | — | — | CN | claimed |
| CN-105602222-B | Fire resistance fibre matrix semi-finished product | 朗盛德国有限责任公司 | 2018-10-12 | — | — | CN | claimed |
| CN-108291122-A | Anionic curable composition | 设计分子有限公司 | 2018-07-17 | — | — | CN | claimed |
| EP-0565785-A1 | Use of glucose transport inhibitors for the treatment for acne | Leveen, Harry H. (US) | 1993-10-20 | — | — | EP | claimed |
| US-20230302030-A1 | COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND USE THEREOF AS INHIBITORS OF RAN GTPase | CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL (CA) | 2023-09-28 | — | — | US | disclosed |
| US-20230302030-A1 | COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND USE THEREOF AS INHIBITORS OF RAN GTPase | CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL (CA) | 2023-09-28 | — | — | US | disclosed |
| CN-111799052-B | Sintered neodymium iron boron magnet with surface function rete | 浙江中杭新材料科技有限公司 | 2022-11-15 | — | — | CN | disclosed |
| EP-3962876-A1 | METHOD FOR IMPROVING CEMENT TOUGHNESS | Saudi Arabian Oil Company (SA) | 2022-03-09 | — | — | EP | disclosed |
| US-11130900-B2 | Method for improving cement toughness | SAUDI ARABIAN OIL COMPANY (SA) | 2021-09-28 | — | — | US | disclosed |
| EP-0210136-A2 | Curable polyether resins | CIBA-GEIGY AG (CH) | 1987-01-28 | — | — | EP | disclosed |
| EP-0189073-A2 | Thermotropic aromatic polyesters with high heat stability, process for their fabrication and their use for the fabrication of moulded articles, of filaments, of fibres and films | BAYER AG (DE) | 1986-07-30 | — | — | EP | disclosed |
| US-4560808-A | CATALYTIC TRANSALKYLATION OF MONOHYDROXY AROMATIC WITH DIHYDROXY COMPOUND | GENERAL ELECTRIC COMPANY (US) | 1985-12-24 | — | — | US | disclosed |
| US-4552876-A | ANTIALLERGENS, ANTIINFLAMMATORY AGENTS | USV PHARMACEUTICAL CORP. (US) | 1985-11-12 | — | — | US | disclosed |
| EP-0157732-A1 | Crosslinkable linear polyether resins | CIBA-GEIGY AG (CH) | 1985-10-09 | — | — | EP | disclosed |
| US-4025399-A | ELECTRICAL, RECORDING LAYER WITH A CONDUCTIVE AGENT, A LEUCO BASE AND A PHENOLIC RESIN | CANON KABUSHIKI KAISHA (JA) | 1977-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230302030-A1 | COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND USE THEREOF AS INHIBITORS OF RAN GTPase | RAN, RANBP1, GDI2 | ESR1 4873/4885ADRA2A 3338/4885SLC6A2 2795/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.